Research firm#41 of 48Last call 12 Nov 2026

Argus Research Stock Ratings & Price Targets

41.8%
Success rate
237 calls measured
Average vs S&P 500 (SPY)
+15.5%

Argus Research made calls on 184 of the stocks we cover over the last year, with 25 upgrades and 17 downgrades; its ratings now are 129 Buy, 16 Hold and 0 Sell. 41.8% of its Buy and Sell calls from November 2022 to November 2025 were right: the stock beat the S&P 500 (SPY) over the next 12 months (a Sell, did worse).

Stocks covered
184
Calls, last 12 months
250
Upgrades
↑ 25
Downgrades
↓ 17
Average upside to its targets
+22.9%
Its ratings now129 Buy · 16 Hold · 0 Sell
Buy89%Hold11%Sell0%

If you followed Argus Research's Buy calls

Each stock held from the firm's Buy call until it cut the rating, or until a year passed without another Buy; the stocks held count alike, beside the S&P 500 (SPY).

See each firm's portfolio and how its calls did, with Plus

Over the last 5 years, on our daily closes before dividends, and only on the stocks we cover today, so stocks that fell away are left out and the returns can look better than they were. Past calls, not a signal.

Track record

Its calls from Nov 2022 to Nov 2025
Success rate
41.8%
Average vs S&P 500 (SPY)
+15.5%
A Buy's average return
+35.2%
S&P 500 (SPY) over the same months +18.2%
Calls measured
237
235 Buy · 2 Sell

Success rate by year

46%
69%
62%
50%
38%
47%
55%
38%
46%
42%
40%
36%
44%
50%
20122013201420152016201720182019202020212022202320242025
2012: 45.5% · 11 calls measured; 2013: 68.8% · 16 calls measured; 2014: 62.2% · 45 calls measured; 2015: 50.0% · 48 calls measured; 2016: 38.0% · 92 calls measured; 2017: 47.1% · 68 calls measured; 2018: 55.3% · 161 calls measured; 2019: 38.2% · 34 calls measured; 2020: 45.6% · 79 calls measured; 2021: 42.2% · 102 calls measured; 2022: 40.3% · 62 calls measured; 2023: 36.4% · 88 calls measured; 2024: 44.3% · 97 calls measured; 2025: 50.0% · 46 calls measured
By year of the call
YearCalls measuredSuccess rateAverage vs S&P 500 (SPY)
20254650.0%+15.6%
20249744.3%+34.5%
20238836.4%+0.0%
20226240.3%-7.2%
202110242.2%+4.0%
20207945.6%+17.9%
20193438.2%-5.5%
201816155.3%+1.6%
20176847.1%+0.4%
20169238.0%-0.5%
20154850.0%+1.2%
20144562.2%-1.1%
20131668.8%+12.8%
20121145.5%+3.0%

Each firm's Buy and Sell calls on the stocks we cover, made over the 3 years to a year ago: a Buy is right when the stock beat the S&P 500 (SPY) over the next 12 months, a Sell when it did worse. Firms are ranked by the success rate their number of calls makes us 95% sure of, so 60 right calls of 100 rank above 20 of 30; then by how much the calls beat the S&P 500 on average. A firm needs 30 calls measured. Measured on our own daily prices, before dividends. Past calls, not a signal.

What it covers, by sector

Technology: 20%Healthcare: 16%Financial Services: 15%Industrials: 13%Consumer Cyclical: 9.8%Utilities: 6.5%Consumer Defensive: 5.4%Others: 14%184stocks
  • Technology20%
  • Healthcare16%
  • Financial Services15%
  • Industrials13%
  • Consumer Cyclical9.8%
  • Utilities6.5%
  • Consumer Defensive5.4%
  • Others14%

The stocks it made calls on over the last year.

The stocks it covers (184)

StockRating nowSincePrice thenPrice nowSince thenPrice target
Buy12 Nov 2026$278$284+2.0%$309+8.9%

A stock's rating is the firm's newest on it over the last year; "since" is the first call of its run with that rating, and the price then is that day's close, in today's shares.

Calls (1,930)

StockActionRatingPrice targetDateSince the call12 months after
AMGN
AMGNAmgen
ReiteratedBuy$460 → $51512 Nov 2026-1.0%—
CAH
CAHCardinal Health
ReiteratedBuy$189 → $30912 Nov 2026+2.0%—

A firm's rating is its newest on a stock over the last year, in its own words (Overweight, Outperform…) and as Buy, Hold or Sell. The move since a call is from the close on its day to the price now.

Source: The firms' ratings and price targets via Financial Modeling Prep; the record from our own daily prices and the S&P 500 (SPY)